Detalhe da pesquisa
1.
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.
Am J Hum Genet
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723632
2.
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecol Oncol
; 141(2): 386-401, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25940428
3.
Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Eur J Hum Genet
; 30(3): 349-362, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027648
4.
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.
Oncotarget
; 9(25): 17735-17755, 2018 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29707144
5.
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Eur J Hum Genet
; 30(5): 630-631, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314806
6.
Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K).
Mol Cytogenet
; 9: 1, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26740820
7.
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.
Orphanet J Rare Dis
; 10: 32, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25886974